182 related articles for article (PubMed ID: 21724804)
1. Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia.
Periasamy S; Singh A; Sahay B; Rahman T; Feustel PJ; Pham GH; Gosselin EJ; Sellati TJ
J Leukoc Biol; 2011 Sep; 90(3):493-507. PubMed ID: 21724804
[TBL] [Abstract][Full Text] [Related]
2. The presence of CD14 overcomes evasion of innate immune responses by virulent Francisella tularensis in human dendritic cells in vitro and pulmonary cells in vivo.
Chase JC; Bosio CM
Infect Immun; 2010 Jan; 78(1):154-67. PubMed ID: 19841074
[TBL] [Abstract][Full Text] [Related]
3. Discordant results obtained with Francisella tularensis during in vitro and in vivo immunological studies are attributable to compromised bacterial structural integrity.
Singh A; Rahman T; Malik M; Hickey AJ; Leifer CA; Hazlett KR; Sellati TJ
PLoS One; 2013; 8(3):e58513. PubMed ID: 23554897
[TBL] [Abstract][Full Text] [Related]
4. A galU mutant of Francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia.
Jayakar HR; Parvathareddy J; Fitzpatrick EA; Bina XR; Bina JE; Re F; Emery FD; Miller MA
BMC Microbiol; 2011 Aug; 11():179. PubMed ID: 21819572
[TBL] [Abstract][Full Text] [Related]
5. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity.
Okan NA; Chalabaev S; Kim TH; Fink A; Ross RA; Kasper DL
mBio; 2013 Feb; 4(1):e00638-12. PubMed ID: 23404403
[TBL] [Abstract][Full Text] [Related]
6. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
Bakshi CS; Malik M; Mahawar M; Kirimanjeswara GS; Hazlett KR; Palmer LE; Furie MB; Singh R; Melendez JA; Sellati TJ; Metzger DW
Vaccine; 2008 Sep; 26(41):5276-88. PubMed ID: 18692537
[TBL] [Abstract][Full Text] [Related]
7. Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity.
Cole LE; Elkins KL; Michalek SM; Qureshi N; Eaton LJ; Rallabhandi P; Cuesta N; Vogel SN
J Immunol; 2006 Jun; 176(11):6888-99. PubMed ID: 16709849
[TBL] [Abstract][Full Text] [Related]
8. A Francisella tularensis live vaccine strain that improves stimulation of antigen-presenting cells does not enhance vaccine efficacy.
Schmitt DM; O'Dee DM; Horzempa J; Carlson PE; Russo BC; Bales JM; Brown MJ; Nau GJ
PLoS One; 2012; 7(2):e31172. PubMed ID: 22355343
[TBL] [Abstract][Full Text] [Related]
9. A study of innate immune kinetics reveals a role for a chloride transporter in a virulent Francisella tularensis type B strain.
Matz LM; Petrosino JF
Microbiologyopen; 2021 Feb; 10(2):e1170. PubMed ID: 33970545
[TBL] [Abstract][Full Text] [Related]
10. Alternative activation of macrophages and induction of arginase are not components of pathogenesis mediated by Francisella species.
Griffin AJ; Crane DD; Wehrly TD; Scott DP; Bosio CM
PLoS One; 2013; 8(12):e82096. PubMed ID: 24324751
[TBL] [Abstract][Full Text] [Related]
11. IKKβ in myeloid cells controls the host response to lethal and sublethal Francisella tularensis LVS infection.
Samaniego S; Marcu KB
PLoS One; 2013; 8(1):e54124. PubMed ID: 23349802
[TBL] [Abstract][Full Text] [Related]
12. Macrophage proinflammatory response to Francisella tularensis live vaccine strain requires coordination of multiple signaling pathways.
Cole LE; Santiago A; Barry E; Kang TJ; Shirey KA; Roberts ZJ; Elkins KL; Cross AS; Vogel SN
J Immunol; 2008 May; 180(10):6885-91. PubMed ID: 18453609
[TBL] [Abstract][Full Text] [Related]
13. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
KuoLee R; Harris G; Conlan JW; Chen W
Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
[TBL] [Abstract][Full Text] [Related]
14. Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia.
Lembo A; Pelletier M; Iyer R; Timko M; Dudda JC; West TE; Wilson CB; Hajjar AM; Skerrett SJ
J Immunol; 2008 Jun; 180(11):7574-81. PubMed ID: 18490759
[TBL] [Abstract][Full Text] [Related]
15. Production of anti-LPS IgM by B1a B cells depends on IL-1β and is protective against lung infection with Francisella tularensis LVS.
del Barrio L; Sahoo M; Lantier L; Reynolds JM; Ceballos-Olvera I; Re F
PLoS Pathog; 2015 Mar; 11(3):e1004706. PubMed ID: 25768794
[TBL] [Abstract][Full Text] [Related]
16. A Francisella tularensis locus required for spermine responsiveness is necessary for virulence.
Russo BC; Horzempa J; O'Dee DM; Schmitt DM; Brown MJ; Carlson PE; Xavier RJ; Nau GJ
Infect Immun; 2011 Sep; 79(9):3665-76. PubMed ID: 21670171
[TBL] [Abstract][Full Text] [Related]
17. MyD88-dependent signaling prolongs survival and reduces bacterial burden during pulmonary infection with virulent Francisella tularensis.
Russo BC; Brown MJ; Nau GJ
Am J Pathol; 2013 Oct; 183(4):1223-1232. PubMed ID: 23920326
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice.
Zhang P; Katz J; Michalek SM
Mol Immunol; 2009 Feb; 46(4):677-87. PubMed ID: 18929413
[TBL] [Abstract][Full Text] [Related]
19. Critical role of IL-25-ILC2-IL-5 axis in the production of anti-Francisella LPS IgM by B1 B cells.
Barbosa CHD; Lantier L; Reynolds J; Wang J; Re F
PLoS Pathog; 2021 Aug; 17(8):e1009905. PubMed ID: 34449811
[TBL] [Abstract][Full Text] [Related]
20. Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism.
Shirey KA; Cole LE; Keegan AD; Vogel SN
J Immunol; 2008 Sep; 181(6):4159-67. PubMed ID: 18768873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
